Parabilis Medicines, Inc. (PBLS)
Current Ratio
12.88×
TTM · Retrieved:

PBLS Current Ratio
What is current ratio?
The current ratio divides current assets by current liabilities to compare short-term resources with short-term obligations.
Compare current ratio
- Lilly (Eli)1.39×LLY
- Johnson & Johnson1.02×JNJ
- AbbVie0.87×ABBV
- Merck & Co.1.35×MRK
- UnitedHealth Group0.74×UNH
- Thermo Fisher Scientific1.81×TMO
- Amgen1.48×AMGN
- Gilead Sciences1.38×GILD
Values are from the market snapshot of .
PBLS current ratio history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Current Ratio | Change |
|---|---|---|
| 0.5169× | −81.83% | |
| 2.8449× | — |
Frequently asked questions: PBLS current ratio
What is Parabilis Medicines, Inc. (PBLS)'s current current ratio?
Parabilis Medicines, Inc. (PBLS)'s latest reported current ratio (TTM) is 12.88× as of Nov 20, 2026. The current ratio divides current assets by current liabilities to compare short-term resources with short-term obligations.
How much historical current ratio data is available for PBLS?
Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s current ratio, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare PBLS's current ratio to peers or set an alert?
You can compare PBLS's current ratio directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on PBLS delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance